These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24356304)

  • 21. Defects in growth hormone receptor signaling.
    Rosenfeld RG; Belgorosky A; Camacho-Hubner C; Savage MO; Wit JM; Hwa V
    Trends Endocrinol Metab; 2007; 18(4):134-41. PubMed ID: 17391978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical GH insensitivity syndrome and severe insulin-like growth factor-I deficiency resulting from compound heterozygous mutations of the GH receptor, including a novel frameshift mutation affecting the intracellular domain.
    Aisenberg J; Auyeung V; Pedro HF; Sugalski R; Chartoff A; Rothenberg R; Derr MA; Hwa V; Rosenfeld RG
    Horm Res Paediatr; 2010; 74(6):406-11. PubMed ID: 20606392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From GHRH to IGF-1 and downstream: clinical phenotypes and biological mechanisms.
    Pfäffle R; Kies W; Klammt J
    Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():529-34. PubMed ID: 22423511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the growth hormone/insulin-like growth factor axis during Balb/c thymus ontogeny and effects of growth hormone upon ex vivo T cell differentiation.
    Kermani H; Goffinet L; Mottet M; Bodart G; Morrhaye G; Dardenne O; Renard C; Overbergh L; Baron F; Beguin Y; Geenen V; Martens HJ
    Neuroimmunomodulation; 2012; 19(3):137-47. PubMed ID: 22261974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of action of GH.
    Müller EE; Rigamonti AE; Cella SG
    J Endocrinol Invest; 2003; 26(10 Suppl):2-15. PubMed ID: 15497655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic analysis of GHR should contain sequencing of all coding exons and specific intron sequences, and screening for exon deletions.
    Walenkamp MJ; Klammt J; Feigerlova E; Losekoot M; van Duyvenvoorde HA; Hwa V; Pfäffle R; Wit JM
    Horm Res Paediatr; 2013; 80(6):406-12. PubMed ID: 24335149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic aspects of growth hormone- and IGF-I-resistant syndromes.
    Savage MO; David A; Camacho-Hubner C; Metherell LA; Clark AJ
    Endocr Dev; 2009; 14():143-50. PubMed ID: 19293581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome).
    Laron Z
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():231-49. PubMed ID: 10698588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotype: genotype relationships in growth hormone insensitivity syndrome.
    Woods KA; Dastot F; Preece MA; Clark AJ; Postel-Vinay MC; Chatelain PG; Ranke MB; Rosenfeld RG; Amselem S; Savage MO
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3529-35. PubMed ID: 9360502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-expression of IGFs and GH receptors (GHRs) in gilthead sea bream (Sparus aurata L.): sequence analysis of the GHR-flanking region.
    Saera-Vila A; Calduch-Giner JA; Pérez-Sánchez J
    J Endocrinol; 2007 Aug; 194(2):361-72. PubMed ID: 17641285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
    Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel mutation of exon 7 in growth hormone receptor mRNA in a patient with growth hormone insensitivity syndrome and neurofibromatosis type I.
    Kang JH; Kim OS; Kim JH; Lee SK; Park YJ; Baik HW
    Int J Mol Med; 2012 Sep; 30(3):713-7. PubMed ID: 22751808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of disorders of IGF-I synthesis and action.
    Wit JM
    Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():538-40. PubMed ID: 22423513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the exon 3-deleted/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency.
    Barbosa EJ; Palming J; Glad CA; Filipsson H; Koranyi J; Bengtsson BA; Carlsson LM; Boguszewski CL; Johannsson G
    J Clin Endocrinol Metab; 2009 Feb; 94(2):639-44. PubMed ID: 19050057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An in vitro model for evaluating peripheral regulation of growth in fish: effects of 17β-estradiol and testosterone on the expression of growth hormone receptors, insulin-like growth factors, and insulin-like growth factor type 1 receptors in rainbow trout (Oncorhynchus mykiss).
    Norbeck LA; Sheridan MA
    Gen Comp Endocrinol; 2011 Sep; 173(2):270-80. PubMed ID: 21703268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGF-I is critical for normal vascularization of the human retina.
    Hellström A; Carlsson B; Niklasson A; Segnestam K; Boguszewski M; de Lacerda L; Savage M; Svensson E; Smith L; Weinberger D; Albertsson Wikland K; Laron Z
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3413-6. PubMed ID: 12107259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial growth hormone insensitivity.
    Johnston LB; Savage MO
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():251-7. PubMed ID: 10698589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of the exon 3 deleted/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults.
    Meyer S; Schaefer S; Stolk L; Arp P; Uitterlinden AG; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Weise A; Pfützner A; Kann PH
    Pharmacogenomics; 2009 Oct; 10(10):1599-608. PubMed ID: 19842933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature.
    Toyoshima MT; Castroneves LA; Costalonga EF; Mendonca BB; Arnhold IJ; Jorge AA
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):500-4. PubMed ID: 17555512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic Defects in the Growth Hormone-IGF-I Axis Causing Growth Hormone Insensitivity and Impaired Linear Growth.
    Savage MO; Hwa V; David A; Rosenfeld RG; Metherell LA
    Front Endocrinol (Lausanne); 2011; 2():95. PubMed ID: 22654835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.